TC Biopharm (Holdings) Plc (TCBP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.32M |
| Enterprise Value | 11.66M |
| P/E Ratio | -0 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.03 |
Fiscal Year
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | June 30, 2024 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.66 |
| Return On Equity | -3.92 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -13.61M |
| Net Income | -5.91M |
| Diluted EPS | -188.09 |
Balance Sheet
| Total Cash | 1M |
| Total Cash/Share | 79.72 |
| Total Debt | 1.65M |
| Total Debt/Equity | 0.67 |
| Current Ratio | 1.2 |
| Book Value Per Share | 86.92 |
Price History
| 52-Week Change | -99.8 |
| 52-Week High | 523.2 |
| 52-Week Low | 0.08 |
| Moving Average 50 Days | 3.18 |
| Moving Average 200 Days | 48.27 |
Statistics
| Average Volume | 377,721 |
| Shares Outstanding | 512,992 |
| % Held by Institutions | 0.22 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | February 10, 2025 |
AD
